“…Pt drugs have achieved great success in the field of cancer chemotherapy. − However, the side effect of these Pt drugs has led chemotherapy research toward alternate anticancer agents such as Ru, Rh, Ir, and Os complexes. − In particular, organometallic half-sandwich complexes of some platinum group metals (Ru, Rh, Ir, and Os) have received considerable attention due to their easy tunable structure, high potency toward cancer cells, and specific mechanism of actions (MoAs). − Generally, the central metals of these 18-electron complexes [(η 5 -Cp)/(η 6 -arene)M(XY)Cl] 0/+ (Cp = functionalized cyclopentadienyl; M = Ru, Rh, Ir, Os; XY = bidentate ligands) have adopted six-coordinated geometry, where the chlorine atom, the bidentate ligand XY, and η 5 -Cp/η 6 -arene occupy one coordination site, two coordination sites, and three coordination sites, respectively (Scheme , I ). It should be noted that hydrolysis of M–Cl bonds, i.e., Cl – /H 2 O exchange, usually represents an activation step for these 18-electron complexes, since M–H 2 O aqua were usually more reactive than the corresponding chloride analogues .…”